Akanda Corp. Welcomes Momentum Towards Cannabis Reform in the United States

Core Viewpoint - Akanda Corp. supports potential changes in US federal cannabis policy, including the rescheduling of cannabis from Schedule I to Schedule III, which would recognize its medical value and lower abuse potential [1]. Group 1: Company Position - Interim CEO Katie Field emphasizes the need for modernization of cannabis policies, advocating for a science-led, public-health framework that could enhance medical research and consumer safety [2]. - Akanda encourages policymakers to focus on measurable outcomes such as expanding medical research and protecting public health while moving consumers away from illicit supply chains [3]. Group 2: Industry Context - The proposed changes in US cannabis policy reflect a similar approach to Canada's Cannabis Act, which established a comprehensive legal framework for cannabis, promoting responsible regulation and public health protections [2]. - The shift in policy could help align federal and state laws in the US, creating standards for responsible legal markets [2]. Group 3: Company Overview - Akanda Corp. is dedicated to cultivating and distributing high-quality cannabis and wellness products, aiming to provide safe and accessible cannabis products globally while promoting sustainable business practices [4].